University of Marburg
Cardiac resynchronization therapy induces reverse LV remodeling
Published in Elder Law Weekly, April 27th, 2005
In a study from Germany, cardiologists monitored reverse LV remodeling and LV function "during the first 6 months" of CRT "in 34 patients (mean age=55.3±13.6 years, 28 men)" with DCM, "left bundle branch block, in stable New York Heart Association class III, and on fixed drug regimen who underwent implantation of CRT systems with or without cardioverter defibrillator back-up."
"QRS-complex duration was reduced from 169.69±19.6 ms (SD) to 144.1±23.4 ms during CRT," R.C. Funck...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Elder Law Weekly
Source: Elder Law Weekly (2005-04-27)
More Articles from Elder Law Weekly
- Decision Resources, Inc.
Alzhemed, Flurizan will be primary drivers in sales of Alzheimer drugs - Karolinska Institute
Aph-1 analyzed, cell surface interactions revealed - Martek Biosciences Corporation
A dietary omega-3 fatty acid could protect against Alzheimer, mouse study shows - Max Planck Unit for Structural Molecular Biology
Anthraquinones examined, effect on Alzheimer paired helical filaments revealed - Pennsylvania Health Care Association
Leaders in Pennsylvania express concern about Medicare, Medicaid cuts - ACI Medical, Inc.
Study demonstrates effectiveness of ArtAssist medical device - More from this issue of Elder Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
